The new face of HFpEF: systemic inflammation

Streszczenie

Systemic inflammation is proposed as background of development and progres of heart failure, especially in heart failure with preserved ejection fraction (HFpEF). High-sensitivity C-reactive protein seems to be an optimal biomarker of systemic inflammation. Knowledge of systemic inflammation is important for new therapeutic fields in HFpEF with potential in inhibition of IL-1β, IL-6 or galectin-3.